Drooid Logo
Back to story perspectives

Full Breakdown

Investigation into Child Deaths Following COVID-19 Vaccination

9/9/2025, 8:19:59 AM

FDA's Investigation Announcement

The U.S. Food and Drug Administration (FDA) is conducting an investigation into reports of child deaths linked to COVID-19 vaccinations, as confirmed by FDA Commissioner Dr. Marty Makary. During a recent interview, Makary stated, “We do know at the FDA — because we've been looking into the [Vaccine Adverse Event Reporting System] database of self-reports — that there have been children who have died from the COVID vaccine.” The investigation aims to provide transparency regarding the safety of COVID-19 vaccines, particularly for children, and is expected to yield a report in the coming weeks.

Context of the Investigation

The investigation follows the revocation of emergency-use authorization for COVID-19 vaccines and comes amid growing concerns about vaccine safety. Makary indicated that the FDA will review autopsy reports, conduct scientific investigations, and interview families affected by these tragic events. He criticized the previous administration for not releasing pertinent data regarding vaccine-related deaths, suggesting that some officials at the Centers for Disease Control and Prevention (CDC) obstructed efforts to gather this information.

Myocarditis Concerns

A significant focus of the investigation is the potential link between COVID-19 vaccinations and myocarditis, particularly in young males. Makary referenced a study indicating that the incidence of myocarditis could be as high as 1 in 2,600 among males aged 17 to 24. He emphasized the need for a thorough risk-benefit analysis regarding vaccination for different age groups, stating, “We want to get good data so people can make a risk-to-benefit analysis for their age group.”

Criticism and Opposition

Health Secretary Robert F. Kennedy Jr. has faced criticism for his stance on vaccines, with some accusing him of spreading misinformation. Critics argue that his comments undermine public health efforts and contribute to vaccine hesitancy. During a Senate hearing, Kennedy claimed that mRNA vaccines “cause serious harm, including death, particularly in young people,” a statement that contradicts CDC findings which report no increased risk of death from the vaccines.

Public Reaction and Broader Implications

The investigation has sparked a mixed public reaction, with some expressing concern over vaccine safety while others argue that vaccines are essential for preventing serious illness. Polling data indicates that while a majority of Americans support childhood vaccinations, there is a notable decline in the perceived importance of these immunizations, particularly among Republicans. This shift in public sentiment may influence future vaccine policies and mandates across various states.

What's Next

The FDA's investigation is set to continue, with results expected to clarify the safety profile of COVID-19 vaccines for children. As the agency prepares to release its findings, the implications for vaccination policies and public health strategies remain significant, especially in light of Florida's recent decision to eliminate school vaccine mandates. The upcoming Advisory Committee on Immunization Practices meeting on September 18 will also be crucial in shaping future vaccine recommendations.

Verbatim Quotes

  • “We do know at the FDA — because we've been looking into the [Vaccine Adverse Event Reporting System] database of self-reports — that there have been children who have died from the COVID vaccine,” — Dr. Marty Makary, FDA Commissioner
  • “We think the public deserves to have that information,” — Dr. Marty Makary, FDA Commissioner
  • “It can be as high as 1 in 2,600 young males between the ages of 17 and 24.” — Dr. Marty Makary, FDA Commissioner
  • “Public health is on the line, and misinformation from the highest levels of government threatens lives.” — Marc Elrich, County Executive

This ongoing investigation highlights the complexities surrounding vaccine safety and public health, as officials navigate the balance between addressing legitimate concerns and maintaining trust in vaccination programs.